A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression

Phase: PHASE2 | Sponsor: University of Washington | Compound: Psilocybin

Status

planned

Institution

University of Washington

Start date

2026-06-01

End date

2028-07-01

Registry ID

NCT07565909

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.